Sleep Number (SNBR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Mar, 2026Executive summary
Leadership transition in April 2025 focused on operational streamlining, cost reduction of $136 million compared to 2024, and extension of the bank agreement through 2027.
Strategic plan “Sleep Number Shifts” targets product simplification, marketing transformation, and expanded distribution to drive growth.
Board and management are committed to enhanced governance, with several proposals resubmitted for shareholder approval after narrowly missing required votes in 2025.
Forward-looking statements highlight ongoing risks and uncertainties, including industry recession and macroeconomic challenges.
Voting matters and shareholder proposals
Seven proposals up for vote: election of three directors, declassification of the board, elimination of supermajority voting for directors and certain transactions, auditor ratification, advisory say-on-pay, and amendment to the 2020 Equity Incentive Plan to add 750,000 shares.
Board recommends voting “For” all proposals, emphasizing governance modernization and alignment with shareholder interests.
Proposals to declassify the board and eliminate supermajority requirements require two-thirds of outstanding shares for approval.
Board of directors and corporate governance
Board reduced from 12 to 7 members since 2025, with significant refreshment and new leadership.
Three director nominees (Eyler, Howard, Mendez) recommended for election; if declassification passes, all directors will stand for annual election starting 2027.
Board diversity in gender, race/ethnicity, age, and tenure is highlighted.
Board committees (Audit, Compensation, CGNC) are fully independent and meet regularly; leadership structure separates Chair and CEO roles.
Shareholder engagement is ongoing, with outreach to holders of over 60% of shares between Jan 2025 and Mar 2026.
Latest events from Sleep Number
- Director elections and key business proposals passed; governance changes did not.SNBR
AGM 2026 - Q1 sales fell 19% to $319M, net loss widened, and turnaround actions and liquidity steps continue.SNBR
Q1 2026 - Shareholders to vote on board declassification, equity plan expansion, and governance reforms.SNBR
Proxy filing - Turnaround strategy and cost reductions set the stage for growth and free cash flow in 2026.SNBR
Investor presentation - Cost savings and new products drive turnaround, setting up double-digit EBITDA growth for 2026.SNBR
Q4 2025 - Major transformation underway with cost cuts, new products, and a focus on value-driven growth.SNBR
28th Annual ICR Conference 2026 - Gross margin hit a three-year high as cost cuts offset a 10% sales decline in Q3.SNBR
Q3 2024 - Gross margin rose and cost cuts offset sales declines, supporting 2024 EBITDA guidance.SNBR
Q2 2024 - Sales declined 11% but margin gains and cost cuts drove improved profitability.SNBR
Q4 2024